TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -0 | -5 | 2 | 16 | 29 | 117 | 26 |
| S | %wins | 67 | 67 | 33 | 33 | 33 | 33 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/23/14 16:03 | 4/22/14 | CUR | Neuralstem, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Garr Richard | MD | DO | CEO | S | -30 | 4.25 | 6 | -7 | 0 | 1,489 | I | 313 | 273 | 77 | 23 | 16 | 0 | 3 | 12 | -1 | -9 | -9 | -21 | -34 | -51 |
6/11/13 18:46 | 6/7/13 | CUR | Neuralstem, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Garr Richard | MD | DO | CEO | S | -9 | 1.42 | 1 | -6 | -3 | 202 | I | 38 | 68 | 29 | 31 | 26 | 6 | 9 | 6 | -1 | -7 | 11 | 43 | 66 | 186 |
2/26/13 17:48 | 2/25/13 | CUR | Neuralstem, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Garr Richard | MD | DO | CEO | S | -14 | 1.15 | 0 | -12 | -5 | 213 | I | -41 | -4 | 96 | 8 | -10 | -12 | -6 | -5 | 1 | 1 | 3 | 26 | 54 | 216 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |